Member Info for Matador78

DOUGLAS, Isle of Man--(BUSINESS WIRE)--Juvenescence Limited (“Juvenescence”), a life sciences company focused on modifying aging and increasing human healthspan, announced today a partnership with Evgen Pharma plc to license its sulforaphane stabilization technology for use in several non-pharmaceutical applications led by its JuvLife division. JuvLife will deploy Evgen’s Sulforadex® stabilization technology to create and manufacture a nutritional health supplement containing a defined and stable dose of sulforaphane, derived from natural sources.

Juvenescence is based on a new understanding of the underlying biological causes of aging, creating evidence-based and science-backed therapies. It is focused on increasing how long people live in health by preventing the diseases of aging in the first place. JuvLife, one of several divisions within Juvenescence, is committed to be the trusted source of scientifically proven, branded health supplements and medical foods that help increase human healthspan and overall quality of life. The Juvenescence team includes highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in the pharmaceutical and consumer health sectors.

Colin Watts, Chief Executive Officer of JuvLife, said: “We are pleased to reach an agreement with Evgen to leverage their scientific technology and expertise to create a differentiated and innovative new product for the global consumer nutritional health market. Sulforaphane is a well-studied natural metabolite derived from cruciferous vegetables that has been shown to activate NRF2 and act as a powerful inducer of the native antioxidant response, helping the body scavenge toxic metabolites and reducing markers of inflammation. In this agreement, we are licensing Evgen’s proprietary technology for the natural extraction and stabilisation of sulforaphane in a potent and cost-advantaged form that we believe is superior to all other sources currently commercially available. Juvenescence has built a reputation as a broad-based healthcare company in the longevity space through strong partnerships with scientific leaders in their specific areas and we are delighted to have such a partner in Evgen.’’

https://us.acrofan.com/detail.php?number=339782

apologies, Juvenescence ...NOT Portage

https://biopharmajournal.com/2020/09/14/juvenescence-ltd-makes-a-24-6-million-payment-in-cash-to-lineage-cell-therapeutics-inc-nyseamericanlctx/

Plucked out by our cannabis correspondent “CBD cakes”

https://www.newswire.ca/news-releases/globalive-technology-announces-equity-incentive-awards-to-key-participants-in-rto-transaction-866239567.html

https://www.youtube.com/watch?v=XcdcfLfxsCA

Helps to visualise

**** poor day today.

Hopefully something next week when all the little wretches know their regimes for the coming months

One of the weirdest sentences ever uttered by you Doggo. Especially when said in a scouse accent

Luke Weils dad managing this.

"Scientific Games"

Luke Weils Manages Andina

http://leisureacq.com/team/

https://www.peachandcoco.com/

The Yooma lifestyle website is redundant. A proper one will be launched via Shopify.

Agro on the board amidst an 800k selling spree.

Nothing changes.

Someone wanted out 100 odd grand to dabble around the markets with. Should be celebrated

Isn't that what everyone's here for to make some money for themselves?

Give them a clap and a cheerio. We'll see in couple of days if they were on the ball or not.

"By becoming part of Regent Pacific, we are planning to help it transform into the first public company to become the engine for the emerging longevity ecosystem and help everyone on the planet live longer and better regardless of their nationality, race, gender, or social status. As part of Regent Pacific, we aim to service the longevity biotechnology industry as well as the health and life insurance industries and become the ultimate instrument to hedge the longevity risk,"said Alex Zhavoronkov, PhD, the founder and CEO of DLI.

https://www.prnewswire.com/news-releases/regent-pacific-enters-longevity-medicine-business-driven-by-leading-ai-technology-through-acquisition-of-deep-longevity-inc-301123205.html

"Damned United"

Anyone holding should consider themselves as such

Same on any given board YNWA its not particular to FFWD

Not while someones selling into any buys it wont no.

15

https://www.streetinsider.com/SEC+Filings/Form+SC+13G+Andina+Acquisition+Corp.+Filed+by%3A+BANK+OF+MONTREAL+CAN/16473251.html

“Lineage has been tremendously successful at monetizing its extensive patent and technology portfolio, most notably through the creation and sale of businesses like AgeX and OncoCyte, and the license or sale of non-core assets. It is worth highlighting that we have not conducted a traditional equity financing in nearly three years, and with an additional $24 million just received from Juvenescence, we believe we have over two years of cash runway based on our current business plan. This cash runway extends well past the expected timing of several major clinical milestones

https://www.businesswire.com/news/home/20200831005164/en/Lineage-Cell-Therapeutics-Receives-24.6-Million-Payment